Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-04-24 @ 6:49 PM
Study NCT ID:
NCT06648902
Status:
COMPLETED
Last Update Posted:
2024-10-18
First Post:
2024-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue
Sponsor:
Kidney Cancer Research Bureau
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KCRB-0102-MEL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None